SCHEMBL10475883

SCHEMBL10475883

CN(Cc1cccc(-c2cnc(N3CCC(c4ncccn4)CC3)nc2)c1)C(=O)CNC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12813836 0.89 AOC3 (0.58) AOC3
SCHEMBL11363925 0.88 AOC3 (0.79) AOC3
SCHEMBL10317994 0.87 AOC3 (0.74) AOC3
SCHEMBL10317060 0.85 AOC3 (0.62) AOC3
SCHEMBL10318214 0.85 AOC3 (0.76) AOC3
SCHEMBL10475868 0.85 AOC3 (0.80) AOC3
SCHEMBL10318107 0.84 AOC3 (0.59) AOC3
SCHEMBL10317972 0.83 AOC3 (0.64) AOC3
SCHEMBL10317439 0.82 AOC3 (0.68) AOC3
SCHEMBL11359583 0.80 AOC3 (0.75) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2479165-B1 GLYCINE COMPOUND ASTELLAS PHARMA INC (JP) 2017-10-25 — — EP disclosed
EP-2479165-A1 GLYCINE COMPOUND Astellas Pharma Inc. (JP) 2012-07-25 — — EP disclosed
Send feedback